GlassScriptPhysician profile
Christy C Park
NPI 1538281316
$15,834.69
in general payments reported to CMS, 2019-2025
35 companies · $2,138 in 2025
The $2,138 reported for 2025 was more than what a typical Rheumatology provider received nationally (typical 2025 total: $894).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,658 · 2020: $1,714 · 2021: $1,409 · 2022: $2,177 · 2023: $2,086 · 2024: $2,652 · 2025: $2,138.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,598 · Education: $278.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,597.77 |
| Education | $277.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $3,391.44 | 2019-2025 | |
| Amgen INC. | $2,649.52 | 2019-2025 | Enbrel, Otezla, Tavneos |
| Pfizer INC. | $1,774.64 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $1,161.35 | 2021-2025 | Saphnelo |
| Novartis Pharmaceuticals Corporation | $1,038.39 | 2019-2025 | |
| Lilly USA, LLC | $983.18 | 2019-2024 | Taltz |
| Janssen Biotech, INC. | $877.80 | 2019-2025 | Tremfya, Stelara |
| Glaxosmithkline, LLC. | $459.21 | 2019-2025 | Benlysta |
| Regeneron Healthcare Solutions, INC. | $304.89 | 2019-2020 | |
| Aurinia Pharma U.S., INC. | $299.51 | 2021-2025 | Lupkynis |
| Genzyme Corporation | $284.99 | 2020-2022 | |
| Mallinckrodt Hospital Products INC. | $247.77 | 2021-2024 | Acthar |
| Boehringer Ingelheim Pharmaceuticals, INC. | $245.81 | 2020-2025 | Ofev |
| Celgene Corporation | $232.92 | 2019 | |
| Ucb, INC. | $216.64 | 2019-2025 | Bimzelx |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $172.90 | 2019-2022 | |
| Organon LLC | $163.88 | 2024-2025 | Hadlima, Renflexis |
| Actelion Pharmaceuticals US, INC. | $160.26 | 2019-2021 | |
| Janssen Scientific Affairs, LLC | $147.80 | 2023 | Tremfya |
| Sandoz INC. | $147.03 | 2024-2025 | Hyrimoz |
| Alexion Pharmaceuticals, INC. | $135.62 | 2019-2025 | Strensiq, Ultomiris |
| Kiniksa Pharmaceuticals International, Plc | $126.93 | 2024 | Arcalyst |
| Ultragenyx Pharmaceutical INC. | $121.82 | 2022 | |
| Fresenius Kabi USA, LLC | $73.48 | 2023-2025 | Idacio |
| E.R. Squibb & Sons, L.L.C. | $69.27 | 2019-2022 | |
| Radius Health, INC. | $67.99 | 2019-2024 | Tymlos |
| Genentech USA, INC. | $57.71 | 2019-2025 | Gazyva |
| Sobi, INC | $56.13 | 2019-2023 | |
| Sanofi-Aventis U.S. LLC | $52.99 | 2022 | |
| Kiniksa Pharmaceuticals, LTD. | $28.38 | 2023 | Arcalyst |
| Kyowa Kirin, INC. | $22.00 | 2023 | Crysvita |
| Takeda Pharmaceuticals U.S.A., INC. | $17.29 | 2019 | |
| Dynavax Technologies Corporation | $17.07 | 2025 | Heplisav-B |
| Scilex Pharmaceuticals INC. | $14.96 | 2024 | |
| Zyla Life Sciences, INC. | $13.12 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christy Park listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.